» Articles » PMID: 7812602

Effects of Chronic Infusions of Alpha-trinositol on Regional and Cardiac Haemodynamics in Conscious Rats

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 1994 Sep 1
PMID 7812602
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

1. Male, Long Evans rats (350-450 g) were chronically instrumented for the measurement of renal, mesenteric and hindquarters haemodynamics, and were given three consecutive, 24 h infusions of vehicle (sterile saline at 0.3 ml h-1, n = 8) or alpha-trinositol (D-myo-inositol-1,2,6-triphosphate) at 5, 20 and 80 mg kg-1 h-1 (0.3 ml h-1; n = 9). During infusion of alpha-trinositol at 5 or 20 mg kg-1 h-1, cardiovascular changes were little different from those seen during saline infusion. However, during infusion of alpha-trinositol at 80 mg kg-1 h-1 there were increases in hindquarters vascular conductance, renal flow and vascular conductance, that were all significantly different from the changes seen in the saline group. Infusion of alpha-trinositol at the high dose in naive rats (n = 8) had even more marked vasodilator effects. 2. Two groups of rats (n = 8 in each), chronically instrumented for the measurement of cardiac haemodynamics, were given 48 h infusions of saline (0.3 ml h-1) or alpha-trinositol (2 mg kg-1 bolus, 80 mg kg-1 h-1 infusion at 0.3 ml h-1). During the infusion of saline, there were slight reductions in heart rate, cardiac index, peak aortic flow, dF/dtmax and central venous pressure. In the animals receiving alpha-trinositol, with the exception of central venous pressure, all the above variables, together with total peripheral conductance, increased. 3. These results, collectively, indicate that incremental infusions of alpha-trinositol do not reveal its full vasodilator potential, possibly due to concurrent activation of counter-regulatory vasoconstrictor mechanisms. However, infusion of alpha-trinositol at a high dose causes substantial increases in renal,mesenteric and hindquarters flows and vascular conductances, supported by significant increases in indices of cardiac inotropism. Such effects, in the absence of significant hypotension, tachycardia or signs of desensitization, give alpha-trinositol a unique cardiovascular profile.

Citing Articles

Additional evidence that the rat renal interstitium contracts in vivo.

Rodriguez-Martinez M, Lopez-Rodriguez J, Flores-Sandoval O, Calvo-Turrubiartes M, Sanchez-Briones M, Silva-Ramirez A PLoS One. 2019; 14(11):e0225640.

PMID: 31774858 PMC: 6881012. DOI: 10.1371/journal.pone.0225640.


Effect of alpha-trinositol on interstitial fluid pressure, oedema generation and albumin extravasation in experimental frostbite in the rat.

Berg A, Aas P, Gustafsson T, Reed R Br J Pharmacol. 1999; 126(6):1367-74.

PMID: 10217530 PMC: 1565914. DOI: 10.1038/sj.bjp.0702442.


Binding sites for alpha-trinositol (inositol 1,2,6-trisphosphate) in porcine tissues; comparison with Ins(1,4,5)P3 and Ins(1,3,4,5)P4-binding sites.

Stricker R, Westerberg E, Reiser G Br J Pharmacol. 1996; 117(5):919-25.

PMID: 8851511 PMC: 1909411. DOI: 10.1111/j.1476-5381.1996.tb15281.x.


Effects of glibenclamide on the regional haemodynamic actions of alpha-trinositol and its influence on responses to vasodilators in conscious rats.

Gardiner S, Kemp P, March J, Fallgren B, Bennett T Br J Pharmacol. 1996; 117(3):507-515.

PMID: 8821541 PMC: 1909315. DOI: 10.1111/j.1476-5381.1996.tb15219.x.


Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats.

Gardiner S, Kemp P, March J, Bennett T Br J Pharmacol. 1995; 116(3):2005-16.

PMID: 8640339 PMC: 1908943. DOI: 10.1111/j.1476-5381.1995.tb16405.x.


References
1.
Pernow J, Modin A, Lundberg J . No effect of D-myo-inositol-1,2,6-triphosphate on vasoconstriction evoked by neuropeptide Y and non-adrenergic sympathetic nerve stimulation. Eur J Pharmacol. 1992; 222(1):171-4. DOI: 10.1016/0014-2999(92)90836-s. View

2.
Schwieler J, Hjemdahl P . D-myo-inositol-1,2,6-triphosphate (PP56) antagonizes nonadrenergic sympathetic vasoconstriction: possible involvement of neuropeptide Y. J Cardiovasc Pharmacol. 1993; 21(3):347-52. DOI: 10.1097/00005344-199303000-00001. View

3.
Feth F, Erdbrugger W, Rascher W, Michel M . Is PP56 (D-myo-inositol-1,2,6-trisphosphate) an antagonist at neuropeptide Y receptors?. Life Sci. 1993; 52(23):1835-44. DOI: 10.1016/0024-3205(93)90003-l. View

4.
Kulka P, Tryba M . Inotropic support of the critically ill patient. A review of the agents. Drugs. 1993; 45(5):654-67. DOI: 10.2165/00003495-199345050-00003. View

5.
Carrington A, Calcutt N, Ettlinger C, Gustafsson T, Tomlinson D . Effects of treatment with myo-inositol or its 1,2,6-trisphosphate (PP56) on nerve conduction in streptozotocin-diabetes. Eur J Pharmacol. 1993; 237(2-3):257-63. DOI: 10.1016/0014-2999(93)90277-o. View